These medications include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)
Emerging multi-agonists such as retatrutide (GLP-1/GIP/glucagon triple agonist) and PTT-A (novel unimolecular peptide tetra-agonist targeting GLP-1, GIP, glucagon and amylin receptors) further expand this concept
Impact on cost and accessibility Compounded semaglutide is cheaper than branded medications
Martina V, Masha A, Gigliardi VR, Brocato L, Manzato E, Berchio A, Massarenti P, Settanni F, Della Casa L, Bergamini S, Iannone A
Gut microbiota, antibiotic therapy and antimicrobial resistance: A narrative review
Paired with Ipamorelin, it is often used in programs targeting central fat and body composition